601.54MMarket Cap
LossP/E TTM
Fulgent Genetics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Fulgent Genetics Inc is 9.06, ranking 24 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -8.70, which is -187.48% below the recent high of 7.61 and -451.84% above the recent low of -48.02.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.